Articles written by: Ellis Scott

Allied Motion Technologies Inc. (AMOT) EPS Estimated At $0.43

Allied Motion Technologies Inc. (AMOT) EPS Estimated At $0.43

Investors sentiment increased to 1.44 in Q3 2018. Its up 0.12, from 1.32 in 2018Q2. It is positive, as 12 investors sold Allied Motion Technologies Inc. shares while 27 reduced holdings. 28 funds opened (more…)

EPS for Bonterra Energy Corp (BNE) Expected At $0.31

Analysts expect Bonterra Energy Corp (TSE:BNE) to report $0.31 EPS on March, 12.They anticipate $0.25 EPS change or 416.67 % from last quarter’s $0.06 EPS. T_BNE’s profit would be $10.35 million giving (more…)

Huazhu Group Limited (HTHT) Analysts See $0.15 EPS

Huazhu Group Limited (HTHT) Analysts See $0.15 EPS

Analysts expect Huazhu Group Limited (NASDAQ:HTHT) to report $0.15 EPS on March, 12.They anticipate $0.03 EPS change or 25.00 % from last quarter’s $0.12 EPS. HTHT’s profit would be $43.71 million giving (more…)

Analysts See $-0.25 EPS for Calyxt, Inc. (CLXT)

Analysts See $-0.25 EPS for Calyxt, Inc. (CLXT)

Analysts expect Calyxt, Inc. (NASDAQ:CLXT) to report $-0.25 EPS on March, 12.They anticipate $0.01 EPS change or 4.17 % from last quarter’s $-0.24 EPS. After having $-0.23 EPS previously, Calyxt, Inc.’s (more…)

$-0.59 EPS Expected for Bellicum Pharmaceuticals, Inc. (BLCM)

$-0.59 EPS Expected for Bellicum Pharmaceuticals, Inc. (BLCM)

Analysts expect Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) to report $-0.59 EPS on March, 12.They anticipate $0.02 EPS change or 3.28 % from last quarter’s $-0.61 EPS. After having $-0.55 EPS previously, (more…)

Tabula Rasa HealthCare, Inc. (TRHC) Analysts See $0.10 EPS

Tabula Rasa HealthCare, Inc. (TRHC) Analysts See $0.10 EPS

Analysts expect Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) to report $0.10 EPS on March, 11.They anticipate $0.04 EPS change or 66.67 % from last quarter’s $0.06 EPS. TRHC’s profit would be $2.05 million (more…)

Tilly's, Inc. (TLYS) Analysts See $0.25 EPS

Tilly's, Inc. (TLYS) Analysts See $0.25 EPS

Investors sentiment increased to 1.74 in 2018 Q3. Its up 0.67, from 1.07 in 2018Q2. It increased, as 12 investors sold Tilly's, Inc. shares while 31 reduced holdings. 43 funds opened positions while (more…)

$-1.01 EPS Expected for Merrimack Pharmaceuticals, Inc. (MACK)

$-1.01 EPS Expected for Merrimack Pharmaceuticals, Inc. (MACK)

Analysts expect Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) to report $-1.01 EPS on March, 11.They anticipate $0.12 EPS change or 13.48 % from last quarter’s $-0.89 EPS. After having $-0.92 EPS previously, (more…)